TMCnet News
Valneva Announces Filing of 2022 Universal Registration Document and US Form 20-FSaint-Herblain (France), March 31, 2023 – Valneva SE (Nasdaq: VALN; Euronext Paris: VLA), a specialty vaccine company, announced today the filing, on March 30 2023, of its 2022 Universal Registration Document (URD) with the French Financial Markets Authority (AMF) under the filing number D.23-0199 and its Form 20-F with the U.S. Securities and Exchange Commission (SEC). Valneva’s 2022 Universal Registration Document includes the Company’s 2022 audited Annual Financial Report, the Management Board Report, the Supervisory Board’s report on Corporate Governance and the Group’s Corporate Social Responsibility Report. These documents are available on Valneva’s website (https://valneva.com/investors/financial-reports/www.amf-france.org) and SEC (www.sec.gov) websites, respectively. Hard copies of these documents may be obtained from the Company, free of charge, upon request at the following address: 6 rue Alain Bombard, 44800 Saint-Herblain, France. About Valneva SE
Attachment ![]() |